NCT00569023View on ClinicalTrials.gov

Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

July 31, 2010

Conditions
Night Blindness
Interventions
DIETARY_SUPPLEMENT

alga Dunaliella bardawil

"Each patients will be treated with four capsules daily of Dunaliella bardawil for 90 days.~Alga Dunaliella bardawil containing 15 mg approximately 50% all-trans beta-carotene and 50% 9-cis beta-carotene isomers"

Trial Locations (1)

52621

Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT00569023 - Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene | Biotech Hunter | Biotech Hunter